{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:01:41Z","timestamp":1780142501650,"version":"3.54.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejim.2026.106853","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T23:36:35Z","timestamp":1774136195000},"page":"106853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Left atrial appendage closure for atrial fibrillation stroke prevention in hereditary hemorrhagic telangiectasia is effective and safe with simplified, time-limited antithrombotic therapy"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6175-1383","authenticated-orcid":false,"given":"Hanny","family":"Al-Samkari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.106853_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2025.106695","article-title":"Left atrial appendage closure in patients with hereditary hemorrhagic telangiectasia and atrial fibrillation: a prospective study and systematic review","author":"Torres-Iglesias","year":"2026","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2026.106853_bib0002","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.106853_bib0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","article-title":"Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients","volume":"245","author":"Kjeldsen","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2026.106853_bib0004","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/bloodadvances.2023011961","article-title":"Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women","volume":"8","author":"Zhang","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.ejim.2026.106853_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(21)00164-2","article-title":"Giving hereditary haemorrhagic telangiectasia the attention it deserves","volume":"8","author":"Al-Samkari","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ejim.2026.106853_bib0006","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/ajh.27756","article-title":"Characterizing the healthcare utilization and costs of hereditary hemorrhagic telangiectasia","volume":"100","author":"Al-Samkari","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2026.106853_bib0007","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jtha.2025.09.024","article-title":"Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale","volume":"24","author":"Al-Samkari","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2026.106853_bib0008","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2026033112","article-title":"Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS)","author":"Al-Samkari","year":"2026","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2026.106853_bib0009","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/ajh.70011","article-title":"Standardization of terminology, definitions, and outcome criteria for bleeding in hereditary hemorrhagic telangiectasia: international consensus report","volume":"100","author":"Al-Samkari","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2026.106853_bib0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10456-021-09807-4","article-title":"Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia","volume":"25","author":"Parambil","year":"2022","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ejim.2026.106853_bib0011","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","article-title":"An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study","volume":"106","author":"Al-Samkari","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2026.106853_bib0012","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa2312749","article-title":"Pomalidomide for epistaxis in hereditary hemorrhagic telangiectasia","volume":"391","author":"Al-Samkari","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106853_bib0013","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa2504411","article-title":"Engasertib versus placebo for bleeding in hereditary hemorrhagic telangiectasia","volume":"393","author":"Al-Samkari","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106853_bib0014","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2026.106853_bib0015","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.2020008739","article-title":"Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care","volume":"137","author":"Al-Samkari","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2026.106853_bib0016","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtha.2022.09.003","article-title":"Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia","volume":"21","author":"Virk","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2026.106853_bib0017","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.thromres.2023.04.017","article-title":"Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: a scoping review","volume":"226","author":"Zhang","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2026.106853_bib0018","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11239-023-02839-1","article-title":"Al-Samkari H. Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia","volume":"56","author":"Virk","year":"2023","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ejim.2026.106853_bib0019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.thromres.2023.07.001","article-title":"Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: a large French cohort study (RETROPLACOTEL)","volume":"229","author":"Grobost","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2026.106853_bib0020","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood.2023021765","article-title":"How I treat bleeding in hereditary hemorrhagic telangiectasia","volume":"144","author":"Al-Samkari","year":"2024","journal-title":"Blood"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526001585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526001585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:12:01Z","timestamp":1780139521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":20,"alternative-id":["S0953620526001585"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106853","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left atrial appendage closure for atrial fibrillation stroke prevention in hereditary hemorrhagic telangiectasia is effective and safe with simplified, time-limited antithrombotic therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106853"}}